National Council for Prescription Drug Programs indexing - billing unit

Manufacturer
National Council for Prescription Drug Programs
Effective date
2012-07-24
Label type
Indexing - Billing Unit
Version
1
Source
full-release
Hydrated at
2026-06-05 01:08:13

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51138-043-30EA - Each51138-0430cb72e4a-1323-400d-97f4-38c19f156ece12012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51138-04351138-043-30

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021210-001UNITHROIDLEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-002UNITHROIDLEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-003UNITHROIDLEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-004UNITHROIDLEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-005UNITHROIDLEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-006UNITHROIDLEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-007UNITHROIDLEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-008UNITHROIDLEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-009UNITHROIDLEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-010UNITHROIDLEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-011UNITHROIDLEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD, RS2000-08-21
N021210-012UNITHROIDLEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2008-02-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 36 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 13 · 516 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021210-001UNITHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-002UNITHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-003UNITHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-004UNITHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-005UNITHROID0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-006UNITHROID0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-007UNITHROID0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-008UNITHROID0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-009UNITHROID0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-010UNITHROID0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-011UNITHROID0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD, RS2000-08-2184e616aacf4f…
2026-09-14 22:38:342026-08N021210-012UNITHROID0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2008-02-0884e616aacf4f…
2026-08-18 06:07:402026-07N021210-001UNITHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-002UNITHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-003UNITHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-004UNITHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-005UNITHROID0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-006UNITHROID0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-007UNITHROID0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-008UNITHROID0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-009UNITHROID0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-010UNITHROID0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-011UNITHROID0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD, RS2000-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-012UNITHROID0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2008-02-08caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021210-001UNITHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-002UNITHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-003UNITHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-004UNITHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-005UNITHROID0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-006UNITHROID0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-007UNITHROID0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-008UNITHROID0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-009UNITHROID0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-010UNITHROID0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-011UNITHROID0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD, RS2000-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021210-012UNITHROID0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2008-02-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021210-001UNITHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021210-002UNITHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021210-003UNITHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021210-004UNITHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-2131067a03dcf5…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 39 · 1,548 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08N021210-001AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-001AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-001AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-002AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-002AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-002AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-003AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-003AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-003AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-004AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-004AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-004AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-005AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-005AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-005AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-006AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-006AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-006AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-007AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-007AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-007AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-008AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-008AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-008AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-009AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-009AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-009AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-010AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-010AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-010AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-011AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-011AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-011AB3384e616aacf4f…
2026-09-14 22:38:342026-08N021210-012AB1184e616aacf4f…
2026-09-14 22:38:342026-08N021210-012AB2284e616aacf4f…
2026-09-14 22:38:342026-08N021210-012AB3384e616aacf4f…
2026-08-18 06:07:402026-07N021210-001AB11caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-001AB22caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-001AB33caaa826d4ba7…
2026-08-18 06:07:402026-07N021210-002AB11caaa826d4ba7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.